Research ExplorerPublicationsHeme oxygenase-1 promoter polymorphism is a predictor of dis...

Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.

Standard

Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors. / Vashist, Yogesh; Uzunoglu, Faik Güntac; Deutsch, Lena; Kalinin, Vjacheslav; Zehler, Oliver; Alzadjali, Adil; Kutup, Asad; Izbicki, Jakob R.; Yekebas, Emre F.

In: J SURG RES, Vol. 166, No. 2, 2, 2011, p. 121-127.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Vashist, Y, Uzunoglu, FG, Deutsch, L, Kalinin, V, Zehler, O, Alzadjali, A, Kutup, A, Izbicki, JR & Yekebas, EF 2011, 'Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.', J SURG RES, vol. 166, no. 2, 2, pp. 121-127. <http://www.ncbi.nlm.nih.gov/pubmed/21236443?dopt=Citation>

APA

Vashist, Y., Uzunoglu, F. G., Deutsch, L., Kalinin, V., Zehler, O., Alzadjali, A., Kutup, A., Izbicki, J. R., & Yekebas, E. F. (2011). Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors. J SURG RES, 166(2), 121-127. [2]. http://www.ncbi.nlm.nih.gov/pubmed/21236443?dopt=Citation

Vancouver

Vashist Y, Uzunoglu FG, Deutsch L, Kalinin V, Zehler O, Alzadjali A et al. Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors. J SURG RES. 2011;166(2):121-127. 2.

Bibtex

@article{296fc1051e71482fbb7f3f7af73a6c7d,
title = "Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.",
abstract = "Current available preoperative diagnostic workup is insufficient to differentiate between benign and malignant pancreatic neuroendocrine tumors (PNET). The aim of the present study was to evaluate the potential prognostic role of the promoter GTn repeat polymorphism (GTn) of the heme oxygenase-1 gene in PNET.",
author = "Yogesh Vashist and Uzunoglu, {Faik G{\"u}ntac} and Lena Deutsch and Vjacheslav Kalinin and Oliver Zehler and Adil Alzadjali and Asad Kutup and Izbicki, {Jakob R.} and Yekebas, {Emre F.}",
year = "2011",
language = "English",
volume = "166",
pages = "121--127",
journal = "J SURG RES",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.

AU - Vashist, Yogesh

AU - Uzunoglu, Faik Güntac

AU - Deutsch, Lena

AU - Kalinin, Vjacheslav

AU - Zehler, Oliver

AU - Alzadjali, Adil

AU - Kutup, Asad

AU - Izbicki, Jakob R.

AU - Yekebas, Emre F.

PY - 2011

Y1 - 2011

N2 - Current available preoperative diagnostic workup is insufficient to differentiate between benign and malignant pancreatic neuroendocrine tumors (PNET). The aim of the present study was to evaluate the potential prognostic role of the promoter GTn repeat polymorphism (GTn) of the heme oxygenase-1 gene in PNET.

AB - Current available preoperative diagnostic workup is insufficient to differentiate between benign and malignant pancreatic neuroendocrine tumors (PNET). The aim of the present study was to evaluate the potential prognostic role of the promoter GTn repeat polymorphism (GTn) of the heme oxygenase-1 gene in PNET.

M3 - SCORING: Journal article

VL - 166

SP - 121

EP - 127

JO - J SURG RES

JF - J SURG RES

SN - 0022-4804

IS - 2

M1 - 2

ER -